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Objectives/design: The aim of the study was to investigate debris captured in ﬁlter embolic protection
devices (EPDs) during carotid artery stenting (CAS) and its possible correlation with plaque echogenicity
and other risk factors.
Materials/methods: Between June 2010 and March 2011, 51 consecutive CAS patients (11 females, mean
age 71.2  7, 10 symptomatic) who underwent 53 procedures were included in this prospective study.
Ultrasonographic Gray-Weale plaque type (IeV, echolucent to echogenic) characterisation was obtained
in all cases. The same type of stent and ﬁlter EPD was used. Filters were collected and, after macroscopic
evaluation, they were examined using the Thin-Prep liquid-based cytology (LBC) technique.
Results: Technical success was 100%. Thirty-day stroke and death rates were 1.8% (1/53) and 0%,
respectively. Visible debris was detected in eight (15%) ﬁlters, whereas LBC revealed the presence of
embolic material particles in 30 ﬁlters (56.6%). The presence of embolic material into the ﬁlter EPD was
2.38-fold increased for every category change from type IV to type I carotid plaques (OR ¼ 2.38, 95%
CI ¼ 1.15e4.93). This association remained robust even after adjustment for age, gender and known
atherosclerotic disease risk factors (OR ¼ 2.26, 95%CI ¼ 1.02e5.02). In multivariate analysis for risk
factors, hypertension was associated with increased presence of embolic material detection in ﬁlter EPD
(OR ¼ 20.4, 95%CI ¼ 1.28e326.1). The time distance from symptom to CAS was inversely correlated with
debris quantity in EPD (Spearman rho 0.716; p ¼ 0.02).
Conclusions: Echolucent plaques, smaller time frame from last symptom and hypertension were asso-
ciated with increased presence of embolic material.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Carotid artery stenting (CAS) has evolved into a potentially
viable alternative to carotid endarterectomy (CEA). CAS offers
advantages because of its minimally invasive nature. Even after the
introduction of embolic protection devices (EPDS) that seem to
reduce stoke risk,1 periprocedural cerebral embolisation impedes
CAS from achieving optimal results. Several risk factors are asso-
ciated with embolisation, including carotid lesion characteristics.2
The Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS)
study reported a signiﬁcant association between plaquetions on this paper, please go
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ciety for Vascular Surgery. Publishemorphology as evaluated with the grey-scale median (GSM) and
neurological outcome after CAS. Patients with echolucent plaques
presented an increased risk for complications in this study.2
Echolucent plaques with low GSM are also associated with
increased procedural embolisation as detected with transcranial
Doppler (TCD) examination.3
In addition to GSM analysis, visual scores, including the Gray-
Weale classiﬁcation, have been described for plaque character-
isation.4,5 Their value in the identiﬁcation of high-risk plaques in
patients undergoing CAS has been not adequately examined using
clinical data, but no association was detected.6 However, cerebral
microembolisation may not always manifest clinically. The amount
of debris captured in ﬁlter EPD is an objective measure of emboli-
sation during the procedure.
The aim of the study was to investigate the incidence and nature
of embolic material captured in ﬁlter EPD during CAS and to
examine the possible correlation with a more practical plaqued by Elsevier Ltd. All rights reserved.
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smaller emboli, a light microscopy technique7 was used in
conjunction with ﬁlter macroscopic examination.
Patients and Methods
All symptomatic patients with greater than 50% and asymp-
tomatic patients with greater than 70% carotid artery stenosis who
were eligible to be offered and accepted to be treated with CAS
between June 2010 and March 2011 were enrolled in this
prospective study. Eligibility for CAS was based on European
Society for Vascular Surgery guidelines.8 For patients without brain
imaging in the past 30 days, preoperative computed tomography
(CT) brain scans were performed in order to reveal possible clini-
cally silent past pathology. Dual anti-platelet treatment with
aspirin (100mg daily) and clopidogrel (75mg daily) was initiated at
least 3 days before and continued for at least 3 months after CAS.8
Forty-three (84%) patients were on statin therapy prior to their
admission to the hospital, while the remaining initiated in-hospital
statin administration for at least 3 days before their intervention.
All patients provided written informed consent form and the study
was approved by the Ethics Committee of our Hospital.
Before the intervention, all patients underwent ultrasono-
graphic assessment of carotid plaque type using the one modiﬁed
by Geroulakos et al.9 Gray-Weale4 classiﬁcation. They were per-
formed by the same operator e who was blinded to the patient’s
clinical status e on a LogiQ Book XP (GE Healthcare, Waukesha, WI,
USA) vascular ultrasound system using an 8-MHz linear probe.
After colour Power Doppler longitudinal imaging of the carotid
bifurcation and internal carotid artery, the no-ﬂow vessel area
(plaque) was characterised as uniformly echolucent (type I),
predominantly echolucent (type II), predominantly echogenic (type
III), uniformly echogenic (type IV) and unclassiﬁed due to heavy
calciﬁcation and acoustic shadows (type V).9
CAS procedure
All procedures were performed at the angiography suite.
Femoral percutaneous access was employed in all cases under local
anaesthesia and systemic heparinisation. Standard access to the
distal common carotid artery (CCA) with a 7-Fr 80-cm-long sheath
was then obtained. Carotid lesions were crossed with the 0.01400
soft-tip ﬁlter EPD guidewire (Emboshield Embolic Protection
System, Abbott Laboratories, Abbott Park, IL, USA). Filter EPD
deployment was performed in a non-tortuous distal internal
carotid artery (ICA) segment. Balloon predilation of the lesion was
not routinely performed. Lesions were stented with tapered X-Act
Abbott Stent System components (Abbott Vascular, Santa Clara, CA,
USA). Additional dilation of the lesionwith balloon angioplasty was
undertaken if angiographic residual stenosis after stent placement
was more than 30%. Intravenous 0.5 mg atropine was administered
to all patients prior to stent deployment and balloon inﬂation in
order to prevent haemodynamic depression.
Filter analysis
Filters were collected and evaluated for macroscopic (qualita-
tive) presence of debris. They were then placed within Cytolyt (a
methanol-based, haemolysing10 buffered preservative solution,
Cytyc Corp, Marlborough, MA, USA) conical containers that were
stirred rinsing debris particles off the ﬁlter membrane. The debris
collected was prepared using the automated Thin-Prep system.
Such a preparation produces a thin layer of cells on a glass slide.11
Light microscopy of 22 optic ﬁelds under the computerised TIS
(Thin-Prep imaging system: operation summary and clinicalinformation) was employed for examination of the slides. The
presence and morphology of debris particles were noted and the
quantity of debris in carotid ﬁlter wasmeasured in a score of zero to
three, with each score pertaining to different ranges of mean
particle numbers per optic ﬁeld. Even though liquid-based cytology
(LBC) is a qualitative technique, its use in conjunction with the
Thin-Prep automated LBC preparation and Imaging system assured
standardisation and homogeneity of the process allowing for
quantiﬁcation to be accurately performed.12,13
Statistical analysis
Continuous variables were expressed as mean  SD. Pearson
correlation coefﬁcient was used to assess the association of quan-
tity of debris in carotid ﬁlter with plaque type. Standard statistical
procedure (non-parametric chi-square distribution with corre-
sponding p-values) was used to assess the differences in demo-
graphic, medical history, carotid artery-related and procedure-
related variables between the groups of patients with and
without material in carotid artery ﬁlter. Multiple logistic regression
analysis was also undertaken, using material in carotid ﬁlter as the
dependent variable and demographic characteristics and plaque
type as predictor variables in a core model. Thereafter, medical
history, carotid artery-related and procedural variables were
alternatively introduced (one at a time) in the core model. Finally,
the correlation coefﬁcient of time between symptoms and CASwith
material in carotid ﬁlter was also calculated by using a non-
parametric Spearman correlation among symptomatic patients.
All p-values0.05were considered statistically signiﬁcant. Analysis
was conducted using the statistical software Statistical Package for
the Social Sciences (SPSS) version 16.0 for Windows (SPSS Inc.,
Chicago, IL, USA).
Results
During the study period, of a total of 68 patients hospitalised for
carotid disease 51 patients (age 71  7, 41 males, 10 symptomatic)
underwent 53 CAS procedures. Seventeen patients underwent CEA
due to ineligibility for CAS or because the CAS team/equipment was
unavailable at the time of needed intervention. Technical success
for the CAS procedures was 100%. Predilationwas used in four cases
(7.5%) andmean duration from CCA access to procedure completion
was 18.19 min  0.88 for asymptomatic and 21.8 min  4.49 for
symptomatic patients (p ¼ 0.45). Thirty-day all-stroke and death
rates were 1.8% (1/53) and 0%, respectively. An 82-year-old male
patient suffered an ipsilateral minor stroke 24 h after the
intervention.
Visible debris was detected in eight (15%) ﬁlters, whereas LBC
revealed the presence of embolic material particles in 30 ﬁlters
(58.8%). These included foam particles with micro-vesicle appear-
ance in 13 (43.3%), pale plaque fragments in 11 (36.7%) and compact
plaque fragments in six (20%) ﬁlters. Cytology attributed soft
texture to foam particles and a more rigid one to compact plaque
fragments (Table 1) (Fig. 1). Distribution of study participants by
demographic, medical history and carotid artery stenosis charac-
teristics between group of patients with and without material in
ﬁlter is shown in Table 2. Plaque type was statistically different
among groups of patients with and without material in ﬁlter
(p ¼ 0.01). Multiple logistic regression analysis with derived odds
ratios (ORs) and 95% conﬁdence intervals (CIs) for material in ﬁlter
are presented in Table 3. A statistically signiﬁcant association was
found between plaque type and material in ﬁlter after adjustment
for age and gender. Noteworthy, progression to one plaque type
category lower (from echogenic to echolucent) was associated with
more than two-fold increased risk for isolation of debris material in
Table 2
Distribution of patients with and without material in ﬁlter embolic protection
devices by demographic, medical history and carotid-related variables. Bold char-
acters represent variable differences reaching statistical signiﬁcance.
Variables Material in ﬁlter p value
Yes No
N (%) N (%)
Age (years) 0.3
65 6 (20.0) 9 (39.1)
66e75 13 (43.3) 7 (30.4)
76þ 11 (36.7) 7 (30.4)
Gender 0.07
Female 4 (13.3) 8 (34.8)
Male 26 (86.7) 15 (65.2)
Ischaemic Heart Disease 0.10
No 17 (56.7) 18 (78.3)
Yes 13 (43.3) 5 (21.7)
Peripheral Arterial Disease 0.42
No 19 (63.3) 17 (73.9)
Yes 11 (36.7) 6 (26.1)
Hypertension
No 1 (3.3) 4 (17.4) 0.09
Yes 29 (96.7) 19 (82.6)
Diabetes 0.34
No 17 (56.7) 16 (69.6)
Yes 13 (43.3) 7 (30.4)
Smoking
No 6 (20.0) 7 (30.4) 0.39
Yes 24 (80.0) 16 (69.6)
Dyslipidemia 0.60
No 6 (20.0) 6 (26.1)
Yes 24 (80.0) 17 (73.9)
Haemodynamic Depression 0.10
No 24 (80.0) 22 (95.7)
Yes 6 (20.0) 1 (4.3)
Symptomatic 0.24
No 26 (86.7) 17 (73.9)
Yes 4 (13.3) 6 (26.1)
% Degree of Carotid Artery Stenosis 0.10
<70 1 (3.3) 5 (21.7)
70e80 9 (30.0) 6 (26.1)
80þ 20 (66.7) 12 (52.2)
Table 1
Characteristics of debris isolated from positive EPD on liquid-based cytology
analysis.
Debris characteristics No. of ﬁlter EPDs
present in (% of
positive ﬁlters)
Subtotal No.
(% of positive ﬁlters)
Cell Morphology
Smooth Muscle Cells 3 (10)
Lymphocytes 4 (13.3) 9 (30)
Endothelial Cells 2 (6.7)
Plaque fragment Morphology
Foam particles 13 (43.3)
Pale plaque fragments 11 (36.7) 30 (100)
Compact plaque fragments 6 (20)
Quantity of debris
þ 11 (36.7)
þþ 13 (43.3)
þþþ 6 (20)
EPD: Embolic Protection Device.
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other co-variates, only hypertension was associated with the
increased presence of embolic material detection in ﬁlter EPD
(OR ¼ 20.4, 95%CI ¼ 1.28e326.1).
The mean debris score was 1.83  0.75 among those with
material in carotid ﬁlter and its correlation with plaque type was
not found to be statistically signiﬁcant (r ¼ 0.17, p ¼ 0.36). Ipsi-
lateral to CAS side symptomatic patient characteristics along with
symptom type, time from symptom to CAS and EPD ﬁndings are
shown in Table 4. A statistically signiﬁcant inverse correlation of
time (days) between symptoms and CAS with debris quantity score
in carotid ﬁlter was observed (r ¼ 0.716; p ¼ 0.02).
Discussion
Thepresence of debris onmacroscopic visible examination at the
time of retrieval was noted in eight ﬁlter EPDs (15%) in our study
while Thin-Prep LBC light microscopy revealed the presence ofFigure 1. Plaque fragments under 40 light microscopy magniﬁcation. A: Foam
particles, B: Pale plaque fragments, C: Compact plaque fragment.
Side of operation 0.69
Right 16 (53.3) 11 (47.8)
Left 14 (46.7) 12 (52.2)
Plaque type 0.01
I 13 (43.3) 6 (26.1)
II 15 (50.0) 10 (43.5)
III 2 (6.7) 2 (8.7)
IV 0 (0.0) 5 (21.7)debris in 58.8%. Cytology showed that all of the positive-for-debris
EPDs contained plaque fragments mainly of foam micro-vesicle
and pale morphology but only nine (30%) contained cell compo-
nents. Statistical signiﬁcancewasnoted for hypertension andplaque
echolucency as factors that increase the presence of debris. More
speciﬁcally, each Gray-Weale type change from IV to I e from
echogenic to more echolucent e increased the odds of debris
isolation by 2.26 times. However, it should be brought to attention
that the positive association of hypertension at multiple regression
is characterisedbyextremelywideCIs and therefore is of lowclinical
relevance. Among symptomatic patients, it was recorded that the
shorter the time frame frommost recent symptom to the procedure,
a signiﬁcantly higher amount of debris was isolated.
The impact of plaque morphology on CAS clinical outcome is
controversial. The ICAROS study analysed the role of GSM on the
risk of stroke during CAS. It concluded that carotid plaque
echolucency, as measured by GSM <25, increases the risk of stroke
in CAS.2 Contrarily, another study performed by Reiter et al.
reported that plaque echolucency did not identify patients with
an increased risk of peri-interventional neurological events. In this
Table 3
Multiple logistic regression derived odds ratios (ORs) and 95% conﬁdence interval
(95%CIs) for material in ﬁlter among 51 participants by demographic, medical
history, procedure-related and carotid-related variables. Bold characters represent
variable ORs reaching statistical signiﬁcance.
Variables Category or increment OR 95%CI p value
Age 65 Reference
66e75 3.51 0.73e16.90 0.12
76þ 2.24 0.48e10.28 0.31
Gender Female Reference
Male 2.68 0.58e12.42 0.21
Plaque type One category
lower (from IV to I)
2.26 1.02e5.02 0.04
Alternatively introduced variables
Duration of CAS 22 min Reference
>22 min 1.93 0.34e10.79 0.45
Ischaemic heart
disease
No Reference
Yes 1.69 0.42e6.72 0.46
Peripheral arterial
disease
No Reference
Yes 1.16 0.30e4.49 0.84
Hypertension No Reference
Yes 20.4 1.28e326.13 0.03
Diabetes No Reference
Yes 1.96 0.50e7.77 0.34
Smoking No Reference
Yes 0.51 0.07e3.53 0.49
Dyslipidemia No Reference
Yes 1.41 0.28e7.11 0.68
Depression No Reference
Yes 3.45 0.33e36.20 0.3
Symptomatic No Reference
Yes 0.33 0.07e1.47 0.15
% Degree of carotid
artery stenosis
<70 Reference
70e80 7.81 0.60e101.90 0.12
80þ 5.3 0.50e57.50 0.17
Side of operation Right Reference
Left 0.82 0.23e2.89 0.76
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classiﬁcation with the standardised Beletsky and Gray-Weale
plaque scores were used.6 Possible issues responsible for this
discrepancy are the inclusion of different centres in the ICAROS
study and the relatively low number of events (23/418) in their
patient cohort.6 We have chosen to perform plaque imaging and
characterisation using the ultrasound-based Gray-Weale classiﬁ-
cation. This method may not be as quantitative as GSM score but it
is cost-effective, practical and there is no need for dedicated
software. It can be easily used in everyday clinical practice with an
acceptable degree of reproducibility when performed in a qualiﬁed
vascular laboratory.14
Studies reporting on the association between plaque charac-
teristics and outcome after CAS have mainly used 30-day clinical
data to report outcome. Microembolisation during CAS, however,Table 4
Symptomatic patients characteristics, time from last symptom and EPD ﬁndings.
Patient
No.
Symptom
type
Time from
symptom to
CAS (days)
Plaque
type
Debris quantity
score (0e3)
Debris
quality
1 TIA 23 II 2 compact
2 Stroke 81 II 0
3 TIA 21 II 0
4 Stroke 137 II 0
5 TIA 10 I 3 pale
6 TIA 7 I 3 foam
7 TIA 163 III 0
8 TIA 30 IV 0
9 Stroke 150 IV 0
10 Stroke 73 III 2 foam
CAS: Carotid Artery Stenting, EPD: Embolic Protection Device, TIA: Transient
Ischaemic Attack.can be sub-clinical and produce silent ischaemic lesions (SILs) in
brain diffusion-weighted magnetic resonance imaging (DW-MRI).
Interestingly, two single-centre randomised controlled trials (RCTs)
and an International Carotid Stenting Study (ICSS) sub-study report
fewer new brain SILs after unprotected CAS than CAS with the use
of EPD, possibly due to additional manoeuvres needed for EPD
deployment.15e17 Furthermore, cerebral microembolisation is not
innocuous and has an impact on cognitive function. Huang et al.18
recently demonstrated that cognitive function may change after
CAS in patients with SIL on DW-MRI. The appearance of new
ischaemic lesions in brain MRI after CAS is signiﬁcantly related to
the plaque morphology, with ﬁbrolipid plaques associated with
higher numbers of new lesions.19
Moreover, embolisation during CAS not only occurs during the
ﬁlter protection (wall apposition20 and membrane pore size), but
also a good number occurs before the ﬁlter is up, and some occurs
after the procedure, with open and closed cell designs. Aortic
arch crossing microembolisation21,22 and ﬁlter EPD manoeuvres
and deployment may also generate emboli as detected by using
TCD during CAS.15 Consequently, debris captured in EPD is not
necessarily a true representation of all emboli that occur associ-
ated with CAS. Plaque morphology is only one of the designators
of embolisation potential during the procedure. Our ﬁndings
suggest that Gray-Weale plaque type should be taken into
account when considering plaque embolisation potential during
intervention.
The amount of debris captured in ﬁlter protection devices is an
objective measure of embolisation during the procedure. Even
though this is a secondary issue, it seems that macroscopic exam-
ination of ﬁlter contents is not adequate. The difference between
macro- and microscopic positives could be explained by the high
presence of small particles invisible to the naked eye that are
trapped by the ﬁlter EPD membrane. The standardised LBC tech-
nique used for the ﬁrst time in this study to evaluate ﬁlter EPD was
introduced in 1996 and most cytology laboratories have adopted it
for Pap test screening.7 Its use in conjunction with the Thin-Prep
System allowed for operator-independent and reproducible quan-
tiﬁcation of debris to be performed.12,13 Analysis of debris captured
in ﬁlter,21,23e25 occlusion26 or ﬂow-reversal27 EPD has been
attempted by several authors who used various methods including
macroscopic observation,27 scanning electron microscopy (SEM)
alone25 or in conjunction with energy dispersive spectroscopy
(EDS)23 and direct light microscopy of the ﬁlter membrane or its
ﬁltrate.21,24,26,28 Visible debris detection rate in our studywas lower
than all aforementioned studies assessing EPD debris after CAS.
Light microscopy debris detection rate was also lower than all
except the one byMaleux et al.21 The difference can be attributed to
the inability to standardise the retrieval and EPD analysis method,
to the subjective nature of visual inspection, to themultiple types of
devices used and due to the fact that most other studies incorpo-
rated primary predilation of the lesion. Additionally, more debris
was isolated when ﬂow-reversal was used possibly due to less
emboli ‘escaping’ to the cerebral circulation.27
The ﬁnding that more debris was isolated from more recently
symptomatic plaques is another indication that these plaques are
more unstable. The Oxford Plaque study,29 a large histology study of
symptomatic carotid plaques collected after CEA, also reported that
recently symptomatic plaques are unstable. There were strong
negative associations between features of instability and time since
stroke. In recently symptomatic patients, an early intervention
should be considered to eliminate the risk of a subsequent embolic
event, along with the choice of a technique that carries the
minimum periprocedural embolisation risk.
One of the limitations of this study is the small sample size
that could inﬂuence statistical analysis. Furthermore, evaluation
T.G. Giannakopoulos et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 627e631 631of carotid plaque echolucency using the modiﬁed Gray-Weale
classiﬁcation does not eliminate investigator bias. However, as
previously reported,14 our intraobserver variability was satisfactory
with a k-value of 0.67 (95%CI, 0.53  0.81). Finally, debris particle
size was deemed inaccurate to be measured because the technique
included steps that caused fragmentation and ﬂattening of the
preparation.11
Conclusion
This study showed that debris detection rate in ﬁlter EPD after
CAS by light microscopy using a standardised cytology technique is
higher than simple macroscopic examination. More echolucent
plaque types and shorter time since the last symptom in symp-
tomatic patients were found to be associated with signiﬁcantly
higher presence of debris in EPD.
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